Stemline Therapeutic (STML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,830 | -24,197 | -6,275 | -2,755 | -1,801 |
| Depreciation Amortization | 403 | 77 | N/A | N/A | N/A |
| Other Working Capital | -1,719 | 2,668 | 1,537 | 601 | -189 |
| Other Operating Activity | 4,433 | 5,334 | 611 | 217 | 128 |
| Operating Cash Flow | $-25,714 | $-16,119 | $-4,127 | $-1,937 | $-1,863 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -16,247 | -40,249 | N/A | N/A | N/A |
| PPE Investments | N/A | -460 | N/A | N/A | N/A |
| Sale Of Investment | 22,632 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $6,385 | $-40,709 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 322 | N/A | N/A |
| Common Stock Issued | 135 | 99,002 | N/A | N/A | 603 |
| Other Financing Activity | 0 | 0 | 0 | 540 | -750 |
| Financing Cash Flow | $135 | $99,002 | $322 | $540 | $-147 |
| Beginning Cash Position | 44,200 | 2,025 | 5,830 | 7,226 | 9,236 |
| End Cash Position | 25,007 | 44,200 | 2,025 | 5,830 | 7,226 |
| Net Cash Flow | $-19,193 | $42,175 | $-3,805 | $-1,397 | $-2,010 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,714 | -16,119 | -4,127 | -1,937 | -1,863 |
| Capital Expenditure | N/A | -460 | N/A | N/A | N/A |
| Free Cash Flow | -25,714 | -16,579 | -4,127 | -1,937 | -1,863 |